Senior Product Manager, Oncology, Hereditary Cancer & Germline Testing

Labcorp is seeking a Senior Product Manager, Oncology (Hereditary Cancer & Germline Testing) to drive product strategy and manage tests and services within Labcorp's oncology portfolio.

Requirements

• Drive lifecycle strategy, product ownership, and management of hereditary cancer and germline testing services from initiation through sunset.
• Develop and execute multi-year product strategies grounded in customer insights, clinical guideline evolution, and reimbursement dynamics.
• Build comprehensive business cases including segmentation, financial modeling, value propositions, and risk management.
• Analyze customer feedback, utilization, access metrics, and portfolio KPIs to drive performance improvement.
• Represent the voice of the customer in product governance and lifecycle forums.
• Facilitate alignment across stakeholders on product evolution, pricing, and portfolio strategy.
• Forecast performance, track adoption, and advise senior leadership on growth opportunities.
• Partner with Product Marketing, Medical Affairs, Science, and Market Access on launch and commercialization strategies.
• Build and maintain relationships with customers, KOLs, professional societies, and advocacy organizations.
• Own the hereditary cancer portfolio roadmap including multi-gene germline panels, targeted testing, and tumor-normal workflows.
• Translate NCCN, ACMG, ASCO, and specialty guidelines into product strategy and testing pathways.
• Design optimized end-to-end customer experiences including eligibility logic, consent models, and structured clinical reporting.
• Lead access and reimbursement strategies emphasizing prevention, early detection, and downstream cost avoidance.
• Drive evidence generation including clinical utility, HEOR, and real-world evidence.
• Segment commercialization strategies across oncology, genetics, OB-GYN, primary care, and health system programs.
• Develop cascade testing strategies to improve identification and testing of at-risk family members.
• Define KPIs including guideline-concordant utilization, payer approval rates, turnaround time, and cascade uptake.
• Cultivate KOL relationships with genetic counselors, geneticists, and hereditary cancer program leaders.

Benefits

• Medical
• Dental
• Vision
• Life
• STD/LTD
• 401(k)
• Paid Time Off (PTO) or Flexible Time Off (FTO)
• Tuition Reimbursement
• Employee Stock Purchase Plan